Haemonetics raises 12-month price target to $115.5
An analyst raised Haemonetics’ 12-month price target to $115.5, implying upside based on the prior reference level.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.